Regulatory Intelligence

Regulatory intelligence encompasses: tracking FDA, EMA, and other agency guidance documents and their implications for development programs; monitoring the regulatory decisions (approvals, refusals, clinical holds) of competitor products; analyzing advisory committee meetings and their precedent-setting recommendations; and staying current on regulatory policy changes that affect product classification, approval pathways, and post-market requirements.

Effective regulatory intelligence requires reading and synthesizing enormous volumes of public information — FDA guidance documents, Federal Register notices, advisory committee briefing packages, competitor label changes, and warning letters — on an ongoing basis. Document intelligence platforms can index these public documents and enable regulatory intelligence analysts to ask specific questions across large document sets: "What has FDA said about this biomarker as a surrogate endpoint?" or "How have FDA advisory committees characterized the risk-benefit of drugs in this class?" with citations to the specific documents.